display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - triple negative
la/mBC - TNBC - L2 - all populationla/mBC - TNBC - L2 - PDL1 positivees-BC - TNBC - NA - all population
atezolizumab plus SoC IMpassion-132, ITT population IMpassion-132, PD-L1 positive population NeoTrip Michel Angelo IMpassion-031 ... ALEXANDRA/IMpassion-030

Study type: